NDC 50989-101 - Double A ORAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50989-101
- Package NDCs from labels
- 50989-101-25, 50989-101-17
- Manufacturer
- Vedco, Inc.
- Effective date
- 2017-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Double "A" Solution | Vedco, Inc. | 2017-01-17 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50989-101-17 | Double AORAL | 1000 mL in 1 BOTTLE | SOLUTION | 1000 | 2 | |
| 50989-101-25 | Double AORAL | 500 mL in 1 BOTTLE | SOLUTION | 500 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Macleods Pharmaceuticals Limited | 89d827c8-91af-4bfd-a846-62e55824e983 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | a9d68a40-75e3-4c5c-b5d7-1d6160527fa7 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | LX22YL083G |
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | ProPharma Distribution | 3f003556-d675-1cf9-e063-6294a90a2cc4 | 2025-09-17 | Warnings, Adverse reactions | SK47B8698T |
| Potassium Chloride | POTASSIUM CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 542e16b0-44db-490f-b44e-4c88a6e3d8b8 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Strides Pharma Science Limited | 0224e5b3-3c49-4e6e-aa78-1abcc6969246 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | HG18B9YRS7 SK47B8698T 660YQ98I10 LX22YL083G |
| Magnesium Sulfate in Water | MAGNESIUM SULFATE IN WATER | Avenacy, LLC | f50f4e06-288c-4b5e-9260-f3fe0a210c0c | 2025-09-15 | Warnings, Adverse reactions | SK47B8698T |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | HG18B9YRS7 SK47B8698T 660YQ98I10 LX22YL083G |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
| GaviLyte - C TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | Lupin Pharmaceuticals,Inc. | a8b15625-ca7c-4d57-9f36-3ac2a6d13665 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
| GAVILYTE G TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Lupin Pharmaceuticals,Inc. | 3978822b-6473-4072-9f80-20ceb9bea355 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Preferred Pharmaceuticals Inc. | 87f369cf-40e5-4f91-aa42-ae986fce6544 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | 9083a01b-2fbe-4e04-9eec-bf4f65950ec7 | 2025-09-09 | Warnings | 660YQ98I10 |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | c14c79ab-85bb-45f2-83d1-1d9c298ffdfd | 2025-09-08 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7c2274f2-5a7f-4a4a-8b7b-44f6ef9a84a4 | 2025-09-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3dfa63fc-f8de-f1e0-e063-6294a90a8d47 | 2025-09-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3dfac7ca-2c2e-e709-e063-6394a90adbb3 | 2025-09-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Kesin Pharma Corporation | 440dcbbb-bb31-d3fd-e063-6294a90ab2f7 | 2025-09-01 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.